Orion Laboratories Pty Ltd T/A Perrigo Australia

Regulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/01/2021

Regulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/01/2021

Regulatory action due to The good had become an exempt good under Schedule 5, Item 8(f) of the Regulations. Exempt goods are not required to be included on the ARTG (paragraph 18(1) of the Act)., effective 19/06/2020

Regulatory action due to The good had become an exempt good under Schedule 5, Item 8(f) of the Regulations. Exempt goods are not required to be included on the ARTG (paragraph 18(1) of the Act)., effective 19/06/2020

Regulatory action due to The good had become an exempt good under Schedule 5, Item 8(f) of the Regulations. Exempt goods are not required to be included on the ARTG (paragraph 18(1) of the Act)., effective 19/06/2020

Regulatory action due to The good had become an exempt good under Schedule 5, Item 8(f) of the Regulations. Exempt goods are not required to be included on the ARTG (paragraph 18(1) of the Act)., effective 19/06/2020

Regulatory action due to The good had become an exempt good under Schedule 5, Item 8(f) of the Regulations. Exempt goods are not required to be included on the ARTG (paragraph 18(1) of the Act)., effective 19/06/2020

Regulatory action due to The good had become an exempt good under Schedule 5, Item 8(f) of the Regulations. Exempt goods are not required to be included on the ARTG (paragraph 18(1) of the Act)., effective 18/06/2020